THE SWARM · FIVE SEATS
Five frontier seats. One rotating judge.
Each model reasons in parallel on the active target. Confidence scores are published with every dossier.
MOST RECENT MISSION
Bicyclic peptides for KRAS G12C inhibition
TARGET
KRAS G12C
MODALITY
Bicyclic peptide
AREA
Non-small cell lung cancer
STATUS
Complete
MODEL 01
✓ DONELiterature Synthesis
CONFIDENCE
74%
MODEL 02
✓ DONENovelty Scout
CONFIDENCE
70%
MODEL 03
✓ DONERed Team
CONFIDENCE
76%
MODEL 04
✓ DONEPatents & Prior Art
CONFIDENCE
65%
MODEL 05
✓ DONEAdversarial Optimiser
CONFIDENCE
61%